Updated: May 19, 2026

Sukumar Nagendran

TSHATaysha Gene Therapies, Inc.SEC CIK: 0001665124
Estimated Net Worth
$11.5 Million
Last Updated: May 19, 2026 11:43 PM EST

Transaction Summary

Total Transactions47
Buy-Sell Ratio1.26
Buy Transactions24
Sell Transactions19

Transaction Volume

Total Volume$5.91M
Net Volume-$5.44M
Buy Volume$233.5K
Sell Volume$5.67M

Trade Analysis

AVG Trade Size$125.65K
Largest Trade$1.13M
Most Active MonthJun
Most Active Year2017

Trading Sentiment

OverallBearish
Recent TradeSelling
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading chart

Monthly Trading Pattern

Loading chart

Past Insider Trading and Trends

Sukumar Nagendran has an estimated net worth of $11.5 Million. This is based on reported shares across multiple companies, which include Health Sciences Acquisitions Corp, Taysha Gene Therapies, Inc., Solid Biosciences Inc., and AveXis, Inc..



2017 was Sukumar Nagendran's most active year for acquiring shares with 10 total transactions. Sukumar Nagendran's most active month to acquire stocks was the month of May. 2017 was Sukumar Nagendran's most active year for disposing of shares, totalling 37 transactions. Sukumar Nagendran's most active month to dispose stocks was the month of October. 2025 saw Sukumar Nagendran paying a total of $590,802.94 for 1,137,822 shares, this is the most they've acquired in one year. In 2025 Sukumar Nagendran cashed out on 1,038,548 shares for a total of $2,504,509.62, their largest year based on trade value.

Holdings & Transactions

Loading…
Loading…
Loading…
Loading…